LDLR and metabolic syndrome: Male and female BTBR WT and OB mice were treated with an LDLR ASO to induce dyslipidemia with elevated TRLs or a control ASO (cASO) for 14 weeks while being placed on an atherogenic diet (Figure 2D; Supplemental Figure 2, A and B; and Supplemental Table 2).